BIN3 antibody (AA 8-240)
Quick Overview for BIN3 antibody (AA 8-240) (ABIN7145784)
Target
See all BIN3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    - 
                                            Binding Specificity
- AA 8-240
- 
                                            Cross-Reactivity
- Human
- 
                                            Purification
- >95%, Protein G purified
- 
                                            Immunogen
- Recombinant Human Bridging integrator 3 protein (8-240AA)
- 
                                            Isotype
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- Recommended dilution: IF:1:50-1:200,
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Buffer
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
- 
                                            Preservative
- ProClin
- 
                                            Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Storage
- -20 °C,-80 °C
- 
                                            Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - BIN3 (Bridging Integrator 3 (BIN3))
- 
                                            Alternative Name
- BIN3
- 
                                            Background
- 
                        Background: Involved in cytokinesis and septation where it has a role in the localization of F-actin. Aliases: BIN3Bridging integrator 3 antibody 
- 
                                            UniProt
- Q9NQY0
 Target
- 
                    
 
                                     
                                     
                                    